0001551986-20-000004.txt : 20200117 0001551986-20-000004.hdr.sgml : 20200117 20200117163208 ACCESSION NUMBER: 0001551986-20-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200117 DATE AS OF CHANGE: 20200117 EFFECTIVENESS DATE: 20200117 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INNOVATE BIOPHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001551986 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-358462 FILM NUMBER: 20533976 BUSINESS ADDRESS: STREET 1: 8480 HONEYCUTT ROAD STREET 2: SUITE 120 CITY: RALEIGH STATE: NC ZIP: 27615 BUSINESS PHONE: 919-275-1933 MAIL ADDRESS: STREET 1: 8480 HONEYCUTT ROAD STREET 2: SUITE 120 CITY: RALEIGH STATE: NC ZIP: 27615 FORMER COMPANY: FORMER CONFORMED NAME: Monster Digital, Inc. DATE OF NAME CHANGE: 20150930 FORMER COMPANY: FORMER CONFORMED NAME: Tandon Digital, Inc. DATE OF NAME CHANGE: 20120611 D 1 primary_doc.xml X0708 D LIVE 0001551986 INNOVATE BIOPHARMACEUTICALS, INC. 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC NORTH CAROLINA 27615 919-275-1933 DELAWARE Monster Digital, Inc. Tandon Digital, Inc. Corporation true Sandeep Laumas 8480 Honeycutt Road Suite 120 Raleigh NC NORTH CAROLINA 27615 Executive Officer Director Jay Madan 8480 Honeycutt Road Suite 120 Raleigh NC NORTH CAROLINA 27615 Executive Officer Director Anthony Maida 8480 Honeycutt Road Suite 120 Raleigh NC NORTH CAROLINA 27615 Director Lorin Johnson 8480 Honeycutt Road Suite 120 Raleigh NC NORTH CAROLINA 27615 Director Saira Ramasastry 8480 Honeycutt Road Suite 120 Raleigh NC NORTH CAROLINA 27615 Director Roy Proujansky 8480 Honeycutt Road Suite 120 Raleigh NC NORTH CAROLINA 27615 Director Edward J Sitar 8480 Honeycutt Road Suite 120 Raleigh NC NORTH CAROLINA 27615 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2020-01-10 false true false 0 2750000 2750000 0 false 1 0 0 0 None other than payments of salary and other compensation in the ordinary course of business. false INNOVATE BIOPHARMACEUTICALS, INC. /s/ Edward J. Sitar Edward J. Sitar Chief Financial Officer 2020-01-17